Qualitative and quantitative testing of circulating cell free DNA (CCFDNA) can be applied for the management of malignant and benign neoplasms. Detecting circulating DNA in cancer patients may help develop a DNA profile for early stage diagnosis in malignancies. The technical issues of obtaining, using, and analyzing CCFDNA from blood will be discussed
Abstract: With the development of new sensitive molecular techniques, circulating cell-free tumour D...
In current molecular cancer diagnostics, using blood samples of cancer patients for the detection of...
With the addition of molecular testing to the oncologist’s diagnostic toolbox, patients have benefit...
Abstract: Qualitative and quantitative testing of circulating cell free DNA (CCFDNA) can be applied ...
Recently, many genome-wide profiling studies provided insights into the molecular make-up of major c...
Precision medicine in the clinical management of cancer may be achieved through the diagnostic platf...
Yi Chang,1,2,* Bhairavi Tolani,2,* Xiuhong Nie,1 Xiuyi Zhi,3 Mu Hu,3 Biao He2 1Department of Respir...
Detection of circulating tumor DNAs (ctDNAs) in cancer patients is an important component of cancer ...
With the development of new sensitive molecular techniques, circulating cell-free tumour DNA contain...
Abstract Peripheral circulating free DNA (cfDNA) is DNA that is detected in plasma or serum fluid wi...
Recent technological advances have enabled the detection and detailed characterization of circulatin...
The analysis of circulating cell free DNA is an important tool for the analysis of tumor resistance,...
The aim of this review is to evaluate the present status of the use of cell-free DNA and its fractio...
Abstract Various recent studies have focused on analyzing tumor genetic material relea...
International audience"Liquid biopsy" focusing on the analysis of circulating tumor cells (CTC) and ...
Abstract: With the development of new sensitive molecular techniques, circulating cell-free tumour D...
In current molecular cancer diagnostics, using blood samples of cancer patients for the detection of...
With the addition of molecular testing to the oncologist’s diagnostic toolbox, patients have benefit...
Abstract: Qualitative and quantitative testing of circulating cell free DNA (CCFDNA) can be applied ...
Recently, many genome-wide profiling studies provided insights into the molecular make-up of major c...
Precision medicine in the clinical management of cancer may be achieved through the diagnostic platf...
Yi Chang,1,2,* Bhairavi Tolani,2,* Xiuhong Nie,1 Xiuyi Zhi,3 Mu Hu,3 Biao He2 1Department of Respir...
Detection of circulating tumor DNAs (ctDNAs) in cancer patients is an important component of cancer ...
With the development of new sensitive molecular techniques, circulating cell-free tumour DNA contain...
Abstract Peripheral circulating free DNA (cfDNA) is DNA that is detected in plasma or serum fluid wi...
Recent technological advances have enabled the detection and detailed characterization of circulatin...
The analysis of circulating cell free DNA is an important tool for the analysis of tumor resistance,...
The aim of this review is to evaluate the present status of the use of cell-free DNA and its fractio...
Abstract Various recent studies have focused on analyzing tumor genetic material relea...
International audience"Liquid biopsy" focusing on the analysis of circulating tumor cells (CTC) and ...
Abstract: With the development of new sensitive molecular techniques, circulating cell-free tumour D...
In current molecular cancer diagnostics, using blood samples of cancer patients for the detection of...
With the addition of molecular testing to the oncologist’s diagnostic toolbox, patients have benefit...
DOI
Add to ORKG